According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$14.91 Billion. In 2025 the company made an earning of S$6.64 Billion, an increase over its 2024 earnings that were of S$6.06 Billion. The earnings displayed on this page is the company's Pretax Income.